` CPMD (CannaPharmaRx Inc) vs S&P 500 Comparison - Alpha Spread

CPMD
vs
S&P 500

Over the past 12 months, CPMD has underperformed S&P 500, delivering a return of -70% compared to the S&P 500's +15% growth.

Stocks Performance
CPMD vs S&P 500

Loading
CPMD
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
CPMD vs S&P 500

Loading
CPMD
S&P 500
Difference
www.alphaspread.com

Performance By Year
CPMD vs S&P 500

Loading
CPMD
S&P 500
Add Stock

Competitors Performance
CannaPharmaRx Inc vs Peers

CannaPharmaRx Inc
Glance View

Market Cap
2.1m USD
Industry
Pharmaceuticals

CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.

CPMD Intrinsic Value
0.001 USD
Overvaluation 70%
Intrinsic Value
Price
Back to Top